Talc and Cancer: What to Know
Talc and Cancer: Risks, Asbestos Concerns & Safety Tips
Talc, a mineral found in some baby powders, cosmetics, medications, and even food, is now under serious review by the U.S. Food and Drug Administration (FDA). This attention comes after decades of debate and thousands of lawsuits linking talc to ovarian cancer—especially from using talc-containing powders in intimate areas. While the science isn’t yet settled, researchers agree on one troubling issue: talc is often contaminated with asbestos, a known cancer-causing substance. And because companies aren’t required to prove their talc is asbestos-free, consumers may be unknowingly exposed.
The strongest concern is for those who use talc-based powders or cosmetics regularly, especially around sensitive areas. Some studies suggest these users may face a higher risk of ovarian cancer. Experts recommend avoiding talc whenever possible and opting for safer alternatives like cornstarch. If you’ve used talc-containing products for many years—especially in your personal care routine—it’s worth discussing with your doctor. You can also check product safety through resources like the Environmental Working Group’s Skin Deep database. (Source: TIME Magazine)
Read the complete article here >
Resources for Living With Stage 4 Cancer
Learn more about topics like talc and cancer, along with other important aspects of living with Stage 4 cancer. Become a member of our community and gain access to trusted resources, upcoming events, medical updates, and invitations to supportive virtual gatherings.
Cancer Vaccines Offer New Hope
Cancer Vaccines Offer New Hope: mRNA Breakthroughs for Stage 4 Cancer
Discover how therapeutic and personalized mRNA cancer vaccines are training the immune system to fight advanced cancers, with promising early clinical trial results.
Cancer vaccines, once considered a distant dream, are becoming a hopeful reality thanks to groundbreaking research inspired by the success of COVID-19 mRNA vaccines. Unlike traditional vaccines designed to prevent illnesses, therapeutic cancer vaccines teach the body’s own immune system how to recognize and attack cancer cells. Memorial Sloan Kettering (MSK) researchers, building on ideas first imagined over a century ago, have significantly advanced these vaccines. Dr. David Scheinberg, a leading researcher at MSK, explains that new technologies now allow vaccines to target multiple proteins specific to cancer cells, making treatments more effective and reducing side effects compared to chemotherapy and radiation.
One promising area is personalized mRNA cancer vaccines, custom-made for each patient based on their tumor’s unique characteristics. Early trials, particularly in pancreatic cancer, have shown encouraging results, with vaccinated patients’ immune cells remaining active for years. Additionally, MSK researchers are developing off-the-shelf vaccines targeting common cancer markers, such as WT1, found in leukemia and ovarian cancer. These vaccines could soon offer accessible, affordable options for many patients. The rapid progress in cancer vaccine development at MSK offers genuine optimism, especially for patients fighting advanced or hard-to-treat cancers. (Source: Memorial Sloan Kettering)
Read the complete article here >
Resources for Living With Stage 4 Cancer
Learn more about topics like mRNA cancer vaccines for stage 4 cancer. Become a member of our community to gain access to trusted resources, as well as online support and education from Dr. Sharon May, Ph.D., LMFT.
